Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid beta-Peptides | 106 | 2023 | 3837 | 7.770 |
Why?
|
Alzheimer Disease | 81 | 2023 | 8596 | 4.040 |
Why?
|
tau Proteins | 21 | 2023 | 2095 | 3.240 |
Why?
|
Peptide Fragments | 41 | 2021 | 5115 | 2.480 |
Why?
|
Amyloid beta-Protein Precursor | 25 | 2018 | 1111 | 2.370 |
Why?
|
Synapses | 22 | 2023 | 1769 | 1.710 |
Why?
|
Long-Term Potentiation | 25 | 2023 | 293 | 1.650 |
Why?
|
Neurodegenerative Diseases | 7 | 2021 | 1087 | 1.570 |
Why?
|
Neuronal Plasticity | 19 | 2023 | 1435 | 1.440 |
Why?
|
Neurons | 29 | 2023 | 9462 | 1.190 |
Why?
|
Prions | 7 | 2023 | 180 | 1.140 |
Why?
|
Brain | 35 | 2023 | 27107 | 1.100 |
Why?
|
Neurotoxins | 5 | 2015 | 240 | 1.090 |
Why?
|
Plaque, Amyloid | 11 | 2019 | 759 | 1.020 |
Why?
|
Neurofilament Proteins | 3 | 2021 | 336 | 0.960 |
Why?
|
Amyloid Precursor Protein Secretases | 9 | 2014 | 620 | 0.930 |
Why?
|
Creutzfeldt-Jakob Syndrome | 2 | 2021 | 93 | 0.900 |
Why?
|
Hippocampus | 26 | 2023 | 3763 | 0.830 |
Why?
|
Amyloid | 9 | 2018 | 841 | 0.750 |
Why?
|
Protein Multimerization | 6 | 2019 | 983 | 0.740 |
Why?
|
Antibodies | 4 | 2018 | 2421 | 0.720 |
Why?
|
PrPC Proteins | 5 | 2023 | 38 | 0.650 |
Why?
|
Antibodies, Monoclonal | 11 | 2018 | 9179 | 0.640 |
Why?
|
Immunoassay | 2 | 2021 | 746 | 0.640 |
Why?
|
CHO Cells | 21 | 2018 | 1388 | 0.640 |
Why?
|
alpha-Synuclein | 5 | 2019 | 750 | 0.630 |
Why?
|
Water | 3 | 2015 | 1410 | 0.600 |
Why?
|
Nootropic Agents | 2 | 2015 | 157 | 0.570 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 11 | 2015 | 3810 | 0.510 |
Why?
|
Rats | 43 | 2023 | 23742 | 0.500 |
Why?
|
Memory Disorders | 4 | 2015 | 1198 | 0.500 |
Why?
|
Cystine | 1 | 2015 | 94 | 0.490 |
Why?
|
Immunization, Passive | 2 | 2015 | 616 | 0.490 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2015 | 54 | 0.480 |
Why?
|
Recombinant Proteins | 7 | 2018 | 6532 | 0.480 |
Why?
|
Rats, Wistar | 14 | 2017 | 1847 | 0.480 |
Why?
|
Animals | 95 | 2023 | 168441 | 0.470 |
Why?
|
Molecular Weight | 9 | 2018 | 2188 | 0.470 |
Why?
|
Dimerization | 10 | 2016 | 891 | 0.470 |
Why?
|
Brain Chemistry | 6 | 2017 | 959 | 0.460 |
Why?
|
Genetic Markers | 1 | 2020 | 2613 | 0.460 |
Why?
|
Cricetinae | 19 | 2014 | 2425 | 0.450 |
Why?
|
Cricetulus | 12 | 2018 | 814 | 0.440 |
Why?
|
Nerve Tissue Proteins | 6 | 2014 | 4414 | 0.430 |
Why?
|
Photosystem II Protein Complex | 1 | 2012 | 18 | 0.420 |
Why?
|
Chromatography, Gel | 11 | 2018 | 646 | 0.420 |
Why?
|
Immunoprecipitation | 9 | 2015 | 878 | 0.420 |
Why?
|
Neurofibrillary Tangles | 2 | 2016 | 457 | 0.410 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 7 | 2015 | 1746 | 0.410 |
Why?
|
Aspartic Acid Endopeptidases | 4 | 2010 | 311 | 0.410 |
Why?
|
Culture Media, Conditioned | 8 | 2015 | 522 | 0.400 |
Why?
|
Avoidance Learning | 2 | 2012 | 248 | 0.390 |
Why?
|
Endopeptidases | 5 | 2003 | 773 | 0.390 |
Why?
|
Down Syndrome | 1 | 2020 | 901 | 0.390 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 22163 | 0.360 |
Why?
|
Synaptic Transmission | 3 | 2014 | 1173 | 0.360 |
Why?
|
Excitatory Postsynaptic Potentials | 7 | 2017 | 369 | 0.360 |
Why?
|
Long-Term Synaptic Depression | 3 | 2019 | 60 | 0.350 |
Why?
|
Protein Binding | 12 | 2021 | 9352 | 0.340 |
Why?
|
Circular Dichroism | 9 | 2016 | 344 | 0.340 |
Why?
|
Neprilysin | 4 | 2008 | 478 | 0.340 |
Why?
|
Solubility | 11 | 2015 | 1091 | 0.330 |
Why?
|
Fenofibrate | 1 | 2009 | 87 | 0.330 |
Why?
|
Mice | 43 | 2023 | 81509 | 0.330 |
Why?
|
Protease Inhibitors | 3 | 2009 | 753 | 0.320 |
Why?
|
Mice, Transgenic | 17 | 2023 | 9535 | 0.310 |
Why?
|
Amino Acid Sequence | 19 | 2021 | 13449 | 0.310 |
Why?
|
Extracellular Space | 3 | 2018 | 563 | 0.310 |
Why?
|
Frontal Lobe | 1 | 2015 | 1420 | 0.310 |
Why?
|
Glutamic Acid | 7 | 2019 | 1176 | 0.300 |
Why?
|
Temporal Lobe | 2 | 2015 | 1695 | 0.300 |
Why?
|
Blotting, Western | 9 | 2015 | 5036 | 0.300 |
Why?
|
Humans | 112 | 2023 | 761423 | 0.290 |
Why?
|
Aged, 80 and over | 20 | 2021 | 58956 | 0.280 |
Why?
|
Cerebellum | 1 | 2014 | 1500 | 0.280 |
Why?
|
Organ Culture Techniques | 3 | 2019 | 794 | 0.280 |
Why?
|
CA1 Region, Hippocampal | 2 | 2019 | 110 | 0.270 |
Why?
|
Kinetics | 10 | 2015 | 6374 | 0.260 |
Why?
|
Parkinson Disease | 5 | 2010 | 2877 | 0.260 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2018 | 1860 | 0.240 |
Why?
|
Male | 58 | 2023 | 360736 | 0.240 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3702 | 0.230 |
Why?
|
Immunotherapy | 2 | 2023 | 4650 | 0.230 |
Why?
|
Molecular Sequence Data | 16 | 2015 | 17644 | 0.230 |
Why?
|
Aged | 23 | 2021 | 169235 | 0.220 |
Why?
|
Protein Conformation | 9 | 2014 | 3969 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2009 | 2273 | 0.210 |
Why?
|
Polymers | 6 | 2012 | 1614 | 0.200 |
Why?
|
Spectrometry, Fluorescence | 2 | 2015 | 685 | 0.200 |
Why?
|
Sodium Dodecyl Sulfate | 4 | 2012 | 126 | 0.200 |
Why?
|
Mass Spectrometry | 3 | 2016 | 2192 | 0.200 |
Why?
|
Mice, Inbred DBA | 2 | 2015 | 621 | 0.190 |
Why?
|
Longevity | 1 | 2009 | 1065 | 0.190 |
Why?
|
Injections, Intraventricular | 5 | 2014 | 225 | 0.190 |
Why?
|
Exosomes | 2 | 2018 | 424 | 0.190 |
Why?
|
Amino Acid Substitution | 4 | 2014 | 1738 | 0.180 |
Why?
|
Insulysin | 4 | 2008 | 49 | 0.180 |
Why?
|
Oxygen | 1 | 2012 | 4228 | 0.180 |
Why?
|
Female | 44 | 2021 | 392581 | 0.180 |
Why?
|
Aminoacyltransferases | 1 | 2021 | 53 | 0.180 |
Why?
|
Disease Models, Animal | 11 | 2019 | 18247 | 0.180 |
Why?
|
Intracellular Fluid | 1 | 2000 | 201 | 0.180 |
Why?
|
Microscopy, Electron | 9 | 2012 | 2561 | 0.170 |
Why?
|
Mutation | 9 | 2018 | 30045 | 0.170 |
Why?
|
Protein Structure, Secondary | 7 | 2013 | 1229 | 0.170 |
Why?
|
Cysteine Endopeptidases | 2 | 2021 | 551 | 0.160 |
Why?
|
Protein Structure, Tertiary | 5 | 2010 | 3792 | 0.160 |
Why?
|
Cognition Disorders | 3 | 2010 | 3979 | 0.160 |
Why?
|
Microscopy, Electron, Transmission | 4 | 2015 | 695 | 0.160 |
Why?
|
Cell Death | 4 | 2018 | 1677 | 0.150 |
Why?
|
Light | 3 | 2012 | 1352 | 0.150 |
Why?
|
Developmental Disabilities | 1 | 2007 | 1509 | 0.150 |
Why?
|
PrPSc Proteins | 1 | 2017 | 32 | 0.150 |
Why?
|
Cross-Linking Reagents | 2 | 2011 | 686 | 0.150 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2821 | 0.150 |
Why?
|
Cells, Cultured | 13 | 2014 | 18964 | 0.140 |
Why?
|
Drug Contamination | 1 | 2018 | 152 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 5 | 2016 | 1540 | 0.140 |
Why?
|
Memory | 3 | 2014 | 2187 | 0.140 |
Why?
|
Middle Aged | 15 | 2021 | 220826 | 0.140 |
Why?
|
Transfection | 5 | 2010 | 5775 | 0.140 |
Why?
|
Growth Hormone | 1 | 2018 | 569 | 0.140 |
Why?
|
Neural Inhibition | 2 | 2011 | 590 | 0.140 |
Why?
|
Microsomes | 2 | 2009 | 251 | 0.130 |
Why?
|
Disease Progression | 4 | 2021 | 13502 | 0.130 |
Why?
|
Presynaptic Terminals | 2 | 2016 | 302 | 0.130 |
Why?
|
Electrophysiology | 5 | 2011 | 1262 | 0.130 |
Why?
|
Iatrogenic Disease | 1 | 2018 | 539 | 0.130 |
Why?
|
Microscopy | 2 | 2018 | 903 | 0.130 |
Why?
|
Protein Denaturation | 3 | 2011 | 242 | 0.120 |
Why?
|
Infusions, Parenteral | 1 | 2015 | 398 | 0.120 |
Why?
|
Metalloendopeptidases | 2 | 1994 | 393 | 0.120 |
Why?
|
Tauopathies | 1 | 2018 | 320 | 0.120 |
Why?
|
Cadaver | 1 | 2018 | 1358 | 0.120 |
Why?
|
Escherichia coli | 3 | 2021 | 4218 | 0.120 |
Why?
|
Antibody Specificity | 2 | 2014 | 1060 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2003 | 2908 | 0.120 |
Why?
|
Immunoglobulin G | 3 | 2015 | 4549 | 0.110 |
Why?
|
Fluorescence | 1 | 2016 | 756 | 0.110 |
Why?
|
Gelatinases | 1 | 1994 | 88 | 0.110 |
Why?
|
Cerebral Cortex | 5 | 2011 | 5776 | 0.110 |
Why?
|
Neurites | 2 | 2018 | 391 | 0.110 |
Why?
|
Ultracentrifugation | 2 | 2011 | 183 | 0.110 |
Why?
|
Substrate Specificity | 3 | 2021 | 1791 | 0.110 |
Why?
|
Scattering, Radiation | 2 | 2010 | 490 | 0.110 |
Why?
|
Tissue Extracts | 2 | 2011 | 141 | 0.110 |
Why?
|
Cell Membrane | 1 | 2003 | 3687 | 0.110 |
Why?
|
Maze Learning | 1 | 2015 | 483 | 0.110 |
Why?
|
Age of Onset | 1 | 2020 | 3304 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2015 | 11073 | 0.110 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2013 | 894 | 0.110 |
Why?
|
Peptide Hydrolases | 2 | 2008 | 621 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 6 | 2015 | 8179 | 0.110 |
Why?
|
Solar Energy | 1 | 2012 | 8 | 0.110 |
Why?
|
Models, Biological | 6 | 2018 | 9469 | 0.110 |
Why?
|
Synaptic Vesicles | 1 | 2014 | 190 | 0.100 |
Why?
|
Cell Line | 5 | 2017 | 15605 | 0.100 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2015 | 151 | 0.100 |
Why?
|
Prealbumin | 1 | 2014 | 222 | 0.100 |
Why?
|
Nanotubes | 1 | 2013 | 82 | 0.100 |
Why?
|
Apolipoproteins E | 1 | 2018 | 1443 | 0.100 |
Why?
|
Protein Folding | 2 | 2010 | 870 | 0.100 |
Why?
|
Microglia | 2 | 2020 | 1361 | 0.100 |
Why?
|
Epitopes | 3 | 2014 | 2507 | 0.100 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 509 | 0.100 |
Why?
|
Calpain | 1 | 2012 | 145 | 0.100 |
Why?
|
Mice, Knockout | 4 | 2017 | 14409 | 0.090 |
Why?
|
Simvastatin | 1 | 2014 | 346 | 0.090 |
Why?
|
Molecular Conformation | 1 | 2012 | 545 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 988 | 0.090 |
Why?
|
Vitamin E Deficiency | 1 | 1991 | 30 | 0.090 |
Why?
|
Pluripotent Stem Cells | 1 | 2018 | 799 | 0.090 |
Why?
|
Catalysis | 1 | 2012 | 774 | 0.090 |
Why?
|
Molecular Structure | 2 | 2015 | 1878 | 0.090 |
Why?
|
Cerebral Amyloid Angiopathy | 3 | 2015 | 895 | 0.090 |
Why?
|
Immunization | 2 | 2005 | 1227 | 0.090 |
Why?
|
Binding Sites | 3 | 2021 | 6055 | 0.090 |
Why?
|
Flurbiprofen | 1 | 2009 | 21 | 0.090 |
Why?
|
Protein Transport | 1 | 2016 | 1966 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14664 | 0.090 |
Why?
|
Benzodiazepinones | 1 | 2009 | 50 | 0.090 |
Why?
|
Lipid Peroxidation | 1 | 1991 | 271 | 0.090 |
Why?
|
Synucleins | 3 | 2004 | 108 | 0.090 |
Why?
|
Congo Red | 5 | 2004 | 48 | 0.090 |
Why?
|
MicroRNAs | 2 | 2018 | 3812 | 0.080 |
Why?
|
Presenilin-1 | 4 | 2018 | 660 | 0.080 |
Why?
|
Glutathione Peroxidase | 1 | 1991 | 258 | 0.080 |
Why?
|
Manganese | 1 | 2012 | 395 | 0.080 |
Why?
|
Treatment Failure | 2 | 2014 | 2642 | 0.080 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 307 | 0.080 |
Why?
|
Oxazines | 1 | 2011 | 350 | 0.080 |
Why?
|
Biocatalysis | 1 | 2009 | 170 | 0.080 |
Why?
|
Models, Molecular | 4 | 2011 | 5439 | 0.080 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1140 | 0.080 |
Why?
|
Nanoparticles | 2 | 2012 | 1955 | 0.080 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 2230 | 0.080 |
Why?
|
Apoptosis | 2 | 2016 | 9488 | 0.080 |
Why?
|
Calcium Carbonate | 1 | 2009 | 62 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5794 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2014 | 1037 | 0.080 |
Why?
|
Acupuncture, Ear | 1 | 2008 | 13 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2010 | 1171 | 0.080 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 396 | 0.080 |
Why?
|
Fibrinolysin | 1 | 2008 | 131 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2015 | 888 | 0.070 |
Why?
|
Selenium | 1 | 1991 | 417 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2225 | 0.070 |
Why?
|
Dipeptides | 1 | 2009 | 391 | 0.070 |
Why?
|
Cohort Studies | 3 | 2020 | 41446 | 0.070 |
Why?
|
Protease Nexins | 1 | 2007 | 39 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3846 | 0.070 |
Why?
|
Protons | 1 | 2012 | 1115 | 0.070 |
Why?
|
Nanotechnology | 1 | 2012 | 712 | 0.070 |
Why?
|
Biophysics | 3 | 2014 | 380 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6922 | 0.070 |
Why?
|
Vitamin E | 1 | 1991 | 872 | 0.070 |
Why?
|
Immunoglobulin M | 1 | 2011 | 1529 | 0.070 |
Why?
|
Drug Synergism | 1 | 2010 | 1755 | 0.070 |
Why?
|
PC12 Cells | 3 | 2000 | 317 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3321 | 0.070 |
Why?
|
Chromosome Pairing | 1 | 2006 | 45 | 0.070 |
Why?
|
Inositol | 1 | 2006 | 215 | 0.060 |
Why?
|
Signal Transduction | 5 | 2018 | 23441 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4354 | 0.060 |
Why?
|
Peptides | 2 | 2012 | 4345 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.060 |
Why?
|
Calcium | 4 | 2014 | 5727 | 0.060 |
Why?
|
Microspheres | 1 | 2009 | 785 | 0.060 |
Why?
|
Diamines | 1 | 2005 | 60 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7584 | 0.060 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 957 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2009 | 1699 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.060 |
Why?
|
Muscular Diseases | 2 | 1999 | 553 | 0.060 |
Why?
|
Thiazoles | 3 | 2019 | 1517 | 0.060 |
Why?
|
Electric Stimulation | 4 | 2014 | 1736 | 0.060 |
Why?
|
Patch-Clamp Techniques | 3 | 2015 | 927 | 0.060 |
Why?
|
Reference Values | 2 | 2007 | 4921 | 0.060 |
Why?
|
Bone Transplantation | 1 | 2009 | 929 | 0.060 |
Why?
|
Rabbits | 2 | 2009 | 4779 | 0.060 |
Why?
|
Lewy Body Disease | 2 | 2003 | 252 | 0.060 |
Why?
|
Phosphorylation | 4 | 2020 | 8320 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1767 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2003 | 66 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2018 | 22168 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3623 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12970 | 0.050 |
Why?
|
Pyridazines | 1 | 2005 | 202 | 0.050 |
Why?
|
Glycine | 3 | 2004 | 666 | 0.050 |
Why?
|
Benzothiazoles | 2 | 2015 | 247 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 2 | 2018 | 1974 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2018 | 11526 | 0.050 |
Why?
|
Valine | 1 | 2004 | 408 | 0.050 |
Why?
|
Behavior | 1 | 2005 | 540 | 0.050 |
Why?
|
Autophagy | 1 | 2010 | 1326 | 0.050 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2004 | 195 | 0.050 |
Why?
|
Gene Deletion | 1 | 2010 | 2667 | 0.050 |
Why?
|
Drug Administration Routes | 2 | 2014 | 150 | 0.050 |
Why?
|
Coloring Agents | 3 | 2000 | 559 | 0.050 |
Why?
|
Osteogenesis | 1 | 2009 | 1273 | 0.050 |
Why?
|
Age Factors | 4 | 2016 | 18400 | 0.050 |
Why?
|
Helix-Turn-Helix Motifs | 1 | 2000 | 14 | 0.050 |
Why?
|
COS Cells | 1 | 2003 | 1130 | 0.050 |
Why?
|
Adult | 8 | 2021 | 221148 | 0.050 |
Why?
|
Pilot Projects | 2 | 2012 | 8633 | 0.050 |
Why?
|
Exercise Therapy | 1 | 2008 | 928 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 8999 | 0.050 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2004 | 655 | 0.040 |
Why?
|
Alanine | 2 | 2001 | 608 | 0.040 |
Why?
|
Extracellular Fluid | 2 | 2013 | 165 | 0.040 |
Why?
|
Cell-Free System | 1 | 2000 | 340 | 0.040 |
Why?
|
Threonine | 1 | 2020 | 271 | 0.040 |
Why?
|
Two-Hybrid System Techniques | 1 | 2021 | 460 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2014 | 6231 | 0.040 |
Why?
|
Antibody Formation | 1 | 2004 | 1398 | 0.040 |
Why?
|
Infant | 2 | 2020 | 36205 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6215 | 0.040 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 162 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 540 | 0.040 |
Why?
|
Amyloidosis | 1 | 2006 | 817 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2009 | 448 | 0.040 |
Why?
|
Low Back Pain | 1 | 2008 | 984 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2009 | 1867 | 0.040 |
Why?
|
Hydrolysis | 2 | 1998 | 664 | 0.040 |
Why?
|
Receptors, Neurokinin-2 | 2 | 1995 | 24 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 452 | 0.040 |
Why?
|
Analgesics | 2 | 2008 | 1070 | 0.040 |
Why?
|
Time Factors | 9 | 2017 | 39975 | 0.040 |
Why?
|
Child | 3 | 2020 | 80162 | 0.040 |
Why?
|
Aspartate Aminotransferase, Cytoplasmic | 1 | 2017 | 2 | 0.040 |
Why?
|
Base Sequence | 1 | 2009 | 12450 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4174 | 0.040 |
Why?
|
Brain Diseases | 1 | 2006 | 1545 | 0.040 |
Why?
|
Body Temperature | 1 | 2000 | 782 | 0.040 |
Why?
|
Ultrasonic Therapy | 1 | 1999 | 215 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42254 | 0.040 |
Why?
|
Synaptosomes | 1 | 2017 | 116 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2017 | 413 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 71 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 88313 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 2016 | 317 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14599 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 215 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2010 | 10766 | 0.030 |
Why?
|
Phototherapy | 1 | 1999 | 368 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 282 | 0.030 |
Why?
|
Ligands | 2 | 2013 | 3271 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59207 | 0.030 |
Why?
|
Microscopy, Atomic Force | 2 | 2010 | 253 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20093 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11902 | 0.030 |
Why?
|
Fatty Acids | 1 | 2003 | 1808 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 576 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 371 | 0.030 |
Why?
|
Ultrasonics | 1 | 1996 | 207 | 0.030 |
Why?
|
Receptors, Neurokinin-3 | 1 | 1994 | 59 | 0.030 |
Why?
|
Naphthalenes | 1 | 2015 | 198 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 290 | 0.030 |
Why?
|
Neurokinin B | 1 | 1994 | 67 | 0.030 |
Why?
|
Buffers | 1 | 2014 | 146 | 0.030 |
Why?
|
Oligopeptides | 3 | 1995 | 1187 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2014 | 89 | 0.030 |
Why?
|
Dementia | 3 | 2015 | 2686 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 2918 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2016 | 421 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2015 | 150 | 0.030 |
Why?
|
Acrylamides | 1 | 2015 | 259 | 0.030 |
Why?
|
Normal Distribution | 1 | 2014 | 272 | 0.030 |
Why?
|
Prospective Studies | 2 | 2020 | 54415 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 559 | 0.030 |
Why?
|
Fetus | 1 | 2000 | 1864 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9418 | 0.030 |
Why?
|
Serum | 1 | 2014 | 210 | 0.030 |
Why?
|
Exocytosis | 1 | 2014 | 320 | 0.030 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1992 | 89 | 0.030 |
Why?
|
Drug Interactions | 2 | 2009 | 1414 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2013 | 150 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2014 | 491 | 0.020 |
Why?
|
Cross Reactions | 1 | 2014 | 818 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1967 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2014 | 411 | 0.020 |
Why?
|
Diffusion | 1 | 2013 | 814 | 0.020 |
Why?
|
Laser Therapy | 1 | 1999 | 1092 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2013 | 429 | 0.020 |
Why?
|
Pain Measurement | 4 | 2008 | 3550 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 1994 | 328 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 1994 | 459 | 0.020 |
Why?
|
Acetylcholine | 1 | 2013 | 629 | 0.020 |
Why?
|
Metals | 1 | 1996 | 718 | 0.020 |
Why?
|
Deafness | 1 | 2015 | 459 | 0.020 |
Why?
|
Receptors, Dopamine D1 | 1 | 1992 | 293 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2013 | 544 | 0.020 |
Why?
|
Tomography | 1 | 2013 | 411 | 0.020 |
Why?
|
Phosphates | 1 | 2014 | 770 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 495 | 0.020 |
Why?
|
Binding, Competitive | 3 | 1998 | 1141 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 398 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1257 | 0.020 |
Why?
|
Silver Staining | 1 | 2010 | 62 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2224 | 0.020 |
Why?
|
Neurofibrils | 1 | 2009 | 75 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 613 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 2687 | 0.020 |
Why?
|
Incidence | 1 | 2008 | 21341 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 1992 | 485 | 0.020 |
Why?
|
Ryanodine | 1 | 2009 | 46 | 0.020 |
Why?
|
Particle Size | 1 | 2014 | 1646 | 0.020 |
Why?
|
Drug Stability | 1 | 2010 | 291 | 0.020 |
Why?
|
Freeze Drying | 2 | 2000 | 101 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 729 | 0.020 |
Why?
|
Bicuculline | 1 | 2009 | 96 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2012 | 859 | 0.020 |
Why?
|
GABA Antagonists | 1 | 2009 | 120 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2012 | 815 | 0.020 |
Why?
|
Cataract | 1 | 2015 | 832 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15838 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1647 | 0.020 |
Why?
|
Range of Motion, Articular | 3 | 2000 | 1586 | 0.020 |
Why?
|
Bone Matrix | 1 | 2009 | 120 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.020 |
Why?
|
Muscle Fatigue | 2 | 1999 | 95 | 0.020 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1994 | 732 | 0.020 |
Why?
|
Osteocalcin | 1 | 2009 | 274 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 664 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2008 | 239 | 0.020 |
Why?
|
Lentivirus | 1 | 2011 | 508 | 0.020 |
Why?
|
Pain | 2 | 2000 | 5071 | 0.020 |
Why?
|
Learning | 2 | 2008 | 1740 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2008 | 268 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22164 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7045 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1903 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 1115 | 0.020 |
Why?
|
Hyperemia | 1 | 2008 | 221 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2875 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1993 | 1517 | 0.020 |
Why?
|
Indoles | 1 | 1995 | 1832 | 0.020 |
Why?
|
Dendritic Spines | 1 | 2008 | 243 | 0.020 |
Why?
|
Half-Life | 1 | 2007 | 652 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 3712 | 0.020 |
Why?
|
Piperidines | 1 | 1995 | 1656 | 0.020 |
Why?
|
Muscles | 1 | 1991 | 1576 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2000 | 2498 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2006 | 613 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2015 | 1906 | 0.020 |
Why?
|
Microtubules | 1 | 2011 | 1074 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2000 | 4946 | 0.020 |
Why?
|
Cattle | 1 | 1991 | 3848 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
Lysosomes | 1 | 2010 | 923 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1970 | 0.020 |
Why?
|
Sample Size | 1 | 2008 | 840 | 0.010 |
Why?
|
RNA Interference | 1 | 2013 | 2831 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1571 | 0.010 |
Why?
|
Self Efficacy | 1 | 2008 | 638 | 0.010 |
Why?
|
Drosophila | 1 | 2011 | 1495 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13009 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2004 | 112 | 0.010 |
Why?
|
Receptors, Notch | 1 | 2008 | 743 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16979 | 0.010 |
Why?
|
Conditioning, Operant | 1 | 2004 | 310 | 0.010 |
Why?
|
Stromal Cells | 1 | 2009 | 1330 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2005 | 728 | 0.010 |
Why?
|
Quinoxalines | 1 | 2004 | 296 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2013 | 7856 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 441 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3576 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5790 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4852 | 0.010 |
Why?
|
Formazans | 1 | 2000 | 8 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2011 | 3395 | 0.010 |
Why?
|
Endopeptidase K | 1 | 2000 | 23 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2415 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 1090 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 2000 | 93 | 0.010 |
Why?
|
Isoelectric Point | 1 | 2000 | 76 | 0.010 |
Why?
|
Double-Blind Method | 3 | 2000 | 12330 | 0.010 |
Why?
|
Sodium Hydroxide | 1 | 2000 | 37 | 0.010 |
Why?
|
Mesencephalon | 1 | 2003 | 332 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 687 | 0.010 |
Why?
|
Neocortex | 1 | 2004 | 417 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2009 | 1685 | 0.010 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2000 | 161 | 0.010 |
Why?
|
Collagen | 1 | 2009 | 2638 | 0.010 |
Why?
|
Codeine | 1 | 2000 | 51 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1435 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2416 | 0.010 |
Why?
|
Static Electricity | 1 | 2000 | 261 | 0.010 |
Why?
|
Biopolymers | 1 | 2000 | 184 | 0.010 |
Why?
|
Filtration | 1 | 2000 | 228 | 0.010 |
Why?
|
Cytosol | 1 | 2003 | 888 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2004 | 1561 | 0.010 |
Why?
|
Ovary | 1 | 2004 | 959 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 840 | 0.010 |
Why?
|
Solvents | 1 | 2000 | 294 | 0.010 |
Why?
|
Hot Temperature | 1 | 2006 | 1440 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2004 | 1076 | 0.010 |
Why?
|
Fear | 1 | 2008 | 1476 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 4016 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1675 | 0.010 |
Why?
|
Elbow | 1 | 1999 | 130 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1998 | 262 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2008 | 2727 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.010 |
Why?
|
Myocardium | 1 | 1991 | 4725 | 0.010 |
Why?
|
Heart | 1 | 1991 | 4405 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2004 | 1891 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2977 | 0.010 |
Why?
|
Culture Media | 1 | 1999 | 896 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 815 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5246 | 0.010 |
Why?
|
Elbow Joint | 1 | 2000 | 359 | 0.010 |
Why?
|
Pregnancy | 2 | 2012 | 29862 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 1340 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 1320 | 0.010 |
Why?
|
Acetaminophen | 1 | 2000 | 554 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2004 | 3159 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8529 | 0.010 |
Why?
|
Dopamine | 1 | 2003 | 1605 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2000 | 3076 | 0.010 |
Why?
|
Pain Threshold | 1 | 1999 | 603 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1995 | 366 | 0.010 |
Why?
|
Up-Regulation | 1 | 2003 | 4124 | 0.010 |
Why?
|
Neuroglia | 1 | 2000 | 955 | 0.010 |
Why?
|
Receptors, Neurokinin-1 | 1 | 1994 | 134 | 0.010 |
Why?
|
Cholesterol | 1 | 2003 | 2902 | 0.010 |
Why?
|
Substance P | 1 | 1994 | 335 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8000 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1994 | 427 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4014 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1995 | 1317 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 9320 | 0.010 |
Why?
|
Quinpirole | 1 | 1992 | 32 | 0.010 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1992 | 54 | 0.010 |
Why?
|
Ergolines | 1 | 1992 | 57 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15262 | 0.010 |
Why?
|
Callithrix | 1 | 1992 | 94 | 0.010 |
Why?
|
Glutamates | 1 | 1993 | 389 | 0.010 |
Why?
|
Parkinson Disease, Secondary | 1 | 1992 | 122 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6178 | 0.010 |
Why?
|
Portal Vein | 1 | 1994 | 431 | 0.010 |
Why?
|
Levodopa | 1 | 1992 | 221 | 0.010 |
Why?
|
Dopamine Agents | 1 | 1992 | 189 | 0.010 |
Why?
|
Benzazepines | 1 | 1992 | 310 | 0.010 |
Why?
|
Astrocytoma | 1 | 1994 | 775 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 12720 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 14026 | 0.000 |
Why?
|
Trachea | 1 | 1995 | 1089 | 0.000 |
Why?
|
Aspirin | 1 | 2000 | 3134 | 0.000 |
Why?
|
Aging | 1 | 2006 | 8705 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2008 | 64651 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6132 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10194 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20556 | 0.000 |
Why?
|
Movement | 1 | 1992 | 1478 | 0.000 |
Why?
|
Swine | 1 | 1993 | 5914 | 0.000 |
Why?
|
Exercise | 1 | 1999 | 5884 | 0.000 |
Why?
|
Kidney | 1 | 1993 | 7049 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1999 | 39117 | 0.000 |
Why?
|